ITH Pharma

ITH Pharma specialises in the provision of of aseptic compounding services for all therapy areas - particularly Parenteral Nutrition, Chemotherapy and CIVAS.

The company was launched in October 2008 by the founding members of Intra-Tech Healthcare, so although we're new, we are experienced and have the understanding of what you require from a supplier.

Our team leads the industry in innovation, providing flexible, cost effective services with both batch and bespoke items for adults, paediatrics and neonates.

Company Growth (employees)
London, GB
Size (employees)
81 (est)-1%
ITH Pharma was founded in 2008 and is headquartered in London, GB

Key People/Management at ITH Pharma

Karen Hamling

Karen Hamling

Managing Director
Adam Bloom

Adam Bloom

Executive Director
Andrew Winstanley

Andrew Winstanley

Commercial Director
Richard Bateman

Richard Bateman

Director of Quality
Shesh Ashsarya

Shesh Ashsarya

Finance Manager

ITH Pharma Office Locations

ITH Pharma has offices in London and Greater London
Greater London, GB (HQ)
10 7 Premier Park Rd
London, GB (HQ)
Premier Park Rd
Show all (2)

ITH Pharma Financials and Metrics

Summary Metrics

Founding Date


ITH Pharma Financials

ITH Pharma's revenue was reported to be £38.6 m in FY, 2017 which is a 25% increase from the previous period.

Revenue (FY, 2017)

38.6 m

Gross profit (FY, 2017)

11.1 m

Gross profit margin (FY, 2017), %


Net income (FY, 2017)

1.7 m

EBITDA (FY, 2017)

2.7 m

EBIT (FY, 2017)

2.3 m

Cash (31-Mar-2017)

9.1 k
GBPFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017


8.2 m12.1 m15.1 m20.4 m26.2 m30.8 m38.6 m

Revenue growth, %


Cost of goods sold

10 m13.6 m18.7 m22.1 m27.5 m

Gross profit

5.1 m6.8 m7.5 m8.6 m11.1 m
GBPFY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017


18.5 k314.4 k38.4 k33.1 k17 k9.1 k

Accounts Receivable

798.9 k1.2 m1.3 m1.2 m2 m3 m3.5 m4.3 m6.1 m


252.7 k315.6 k587.5 k766.1 k1.2 m1.4 m1.4 m1.6 m3 m

Current Assets

1.1 m1.5 m2.4 m2.4 m3.8 m4.8 m5.4 m6.2 m9.6 m
    GBPFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

    Net Income

    34.1 k335 k547.1 k947.3 k282.2 k494.6 k1.7 m

    Cash From Operating Activities

    (198.5 k)412.8 k148.6 k605.7 k799.8 k276.4 k(489.4 k)

    Cash From Financing Activities

    262.9 k(160.2 k)(305.9 k)(1.1 m)29.8 k

    Net Change in Cash

    (118 k)88.9 k(101.8 k)(744.2 k)447.4 k(739.7 k)(1.8 m)
      GBPY, 2017


      723.9 k

      Financial Leverage

      3.6 x
      Show all financial metrics

      ITH Pharma's Web-traffic and Trends

      ITH Pharma Company Life and Culture

      You may also be interested in